Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Myeloid Leukemia Risk Factors
Research from Edouard Herriot Hospital yields new data on acute myeloid leukemia risk factors
March 23rd, 2008
Research findings, 'Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience,' are discussed in a new report. According to recent research from Lyon, France, "The poor prognosis for elderly patients with acute myeloid leukemia (AML) raises questions regarding the benefit of treating them with intensive chemotherapy. The impact of initial characteristics on prognosis has been addressed previously in elderly patients; however, very few data are available regarding the prognostic value of immunophenotypic characteristics in this setting." "The authors investigated expression of the membrane antigens CD13, CD15,...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-23)
|
